Vigilant Biosciences, a Fort Lauderdale business that develops systems for early detection of cancer, has signed an exclusive sales and marketing partnership with Eurobio.

The company will distribute Vigilant’s OncAlert Oral Cancer Risk Assessment System and the and the OncAlert Oral Cancer CD44 + Total Protein Lab Test in France, Morocco and Tunisia.

Financial terms were not disclosed.

Headquartered in Les Ulis, France, Eurobio is a developer, manufacturer and marketer of in-vitro diagnostic products for biotechnology, research and pharmaceutical laboratories.

Source: Sun Sentinel